Free Newsletter
U.K. proffers €56M for 12 new research units
A dozen new Biomedical Research Units created under the U.K.'s National Institute for Health Research will receive more than €56 million to fund translational work on ailments that include obesity and heart disease. Each of the BRUs match a university with the National Health Service (NHS) Trust. And the public funding is intended to finance work in research areas that are usually starved of funding. Their work is also intended to complement R&D programs at the 12 existing NIHR Biomedical Research Centres.
"Together, these are among the most outstanding centres of medical research in the world," said the Department of Health.
- read the story in PharmaTimes
Related Articles:
Biopharma execs sign on to tout UK's R&D work. U.K. report
Market volatility spurs M&A talks at UK biotechs. M&A report
U.K. to require more disclosure of drug trial data. Drug trial report
U.K. researchers driven out by tough regulations. U.K. report
GSK looks abroad for more scientists as U.K. shortage grows. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: